Organization
Osiris Therapeutics, Inc.
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
Osiris Therapeutics, Inc.
... - Medipost - Mesoblast - NuVasive - Ocata Therapeutics - Organogenesis - Osiris Therapeutics - Pharmicell - Regenerys - TiGenix - UniQure - Vericel Corporation ...
... York (November 3, 2017, 5:23 PM EDT) -- Medical products maker Osiris Therapeutics Inc. and four top executives were accused of fraud by the U.S. ...
... lawful accounting and misleading investors in the process. The SEC alleges that Osiris Therapeutics routinely overstated company performance and issued fraudulent financial statements for a ...
... COLUMBIA, Md., Nov. 02, 2017 (GLOBE NEWSWIRE) -- Osiris Therapeutics, Inc. (OTC Pink:OSIR) (the "Company"), a leading regenerative medicine company focused on ...
... COLUMBIA, Md., Oct. 30, 2017 (GLOBE NEWSWIRE) -- Osiris Therapeutics, Inc. (OTC Pink:OSIR) (the "Company"), a leading regenerative medicine company focused on ...
... COLUMBIA, Md. - Osiris Therapeutics, Inc. (Pink Sheets: OSIR), a leading regenerative medicine company focused on developing ...
... Surgical, Inc., Integra LifeSciences Corporation, Globus Medical Inc, Straumann Holding AG, Osiris Therapeutics, Inc., Arthrex, Inc., Xtant Medical, Alliqua BioMedical, Inc, C. R. Bard, Inc ...
... Osiris Therapeutics, Inc. has announced the publication of a new peer reviewed manuscript entitled ...
... Most recently, Mr Montgomery served as the President and CEO for Osiris Therapeutics, Inc., a market leading company focused on advancing regenerative medicine. He was ...
... Technologies 14.14 StemCells Inc 14.13 Pfizer 14.12 Pluristem Therapeutics 14.11 Plasticell 14.10 Osiris Therapeutics 14.9 NuVasive 14.8 Mesoblast 14.7 MEDIPOST 14.6 Cytori Therapeutics 14.5 Cynata ...
... Corp , MedImmune , MEDIPOST, Merck , Mesoblast, Millennium Pharmaceutical , NuVasive, Osiris Therapeutics, Plasticell, Pluristem Therapeutics, Pfizer, SanBio Current Stem Cell Trials, Seattle Genetics ...
... Challenges, Trends & Drivers - Key Vendors are Holostem, JCR Pharmaceuticals, Organogenesis, Osiris Therapeutics & Vericel - Research and Markets ...
... - Vericel Corporation - UniQure - TiGenix - Regenerys - Pharmicell - Osiris Therapeutics - Organogenesis - Ocata Therapeutics - NuVasive - Mesoblast - Medipost ...
... partially fund the previously announced $10 million, 2017 exploration program at the Osiris and Rau Projects which are not subject to the Barrick Earn-in "We ...
... Mr. Montgomery served as the President and Chief Executive Officer for Osiris Therapeutics, Inc., a market leading company focused on advancing regenerative medicine. He was ...
... involved in the development and commercialization of stem cell therapy products. Osiris Therapeutics, Inc. (U.S.), MEDIPOST Co., Ltd. (South Korea), Anterogen Co., Ltd. (South Korea), ...
... Poxel - PhaseBio Pharmaceuticals - Pfizer - Perle Biosciences - Peptron - Osiris Therapeutics - Orexigen Therapeutics - Oramed - NuSirt Biopharma - Novartis - ...
... disease, diabetes, and other conditions. Covered in this report - Vericel - Osiris Therapeutics - Organogenesis - JCR Pharmaceuticals - Holostem Advanced Therapies Key vendors ...
... COLUMBIA, Md. , Feb. 10, 2017 (GLOBE NEWSWIRE) -- Osiris Therapeutics, Inc. (NASDAQ:OSIR) is pleased to announce that its Board of Directors, at ...
... COLUMBIA, Md., Jan. 13, 2017 (GLOBE NEWSWIRE) -- Osiris Therapeutics, Inc. (NASDAQ:OSIR), announced today that �a new peer-reviewed manuscript "Human cryopreserved viable ...
... fuel and commercial endeavors. NASA's interest in Lucy and Psyche, along with OSIRIS-REx, which is en route to the asteroid Bennu, and the Dawn mission, ...
... Plc, RTI Surgical, IOP Ophthalmics, Organogenesis Inc, BioPolymer GmbH & Co. KG, Osiris Therapeutics, Baxter International, Vericel, Aplhatec Spine Inc, Maxigen Biotech Inc, Auto Tissue ...
... of the Company to successfully maintain its NASDAQ listing. . (OSIR-G) About Osiris Therapeutics Osiris Therapeutics, Inc., based in Columbia, Maryland, is a world leader ...
... COLUMBIA, Md., Nov. 22, 2016 (GLOBE NEWSWIRE) -- Osiris Therapeutics, Inc. (NASDAQ:OSIR) announced today that a new peer-reviewed manuscript by physician and ...
... COLUMBIA, Md., Nov. 21, 2016 (GLOBE NEWSWIRE) -- Osiris Therapeutics, Inc. (NASDAQ:OSIR) (the "Company") today provided an update regarding the status of ...
Want to see the full history of news or view news on a particular date? Upgrade to RelSci Professional now!
Start My Free Trial ➤